Holen Sie sich die Stockscreener-App
9.53
1.38%
0.13
Handel nachbörslich:
9.53
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NEOG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$9.40
Offen:
$9.45
24-Stunden-Volumen:
1.91M
Relative Volume:
0.69
Marktkapitalisierung:
$2.07B
Einnahmen:
$870.54M
Nettoeinkommen (Verlust:
$-608.78M
KGV:
-3.3979
EPS:
-2.8047
Netto-Cashflow:
$4.09M
1W Leistung:
-0.10%
1M Leistung:
+1.49%
6M Leistung:
+54.46%
1J Leistung:
+85.05%
1-Tages-Spanne:
$9.29
$9.58
1-Wochen-Bereich:
$8.98
$9.6835
52-Wochen-Spanne:
$4.5305
$11.43
Neogen Corp Stock (NEOG) Company Profile
Firmenname
Neogen Corp
Sektor
Branche
Telefon
(517) 372-9200
Adresse
620 LESHER PLACE, LANSING
Compare NEOG vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEOG
Neogen Corp
|
9.53 | 2.05B | 870.54M | -608.78M | 4.09M | -2.8047 |
ABT
Abbott Laboratories
|
89.46 | 158.14B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
294.73 | 120.69B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
80.00 | 103.96B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.50 | 85.62B | 20.62B | 3.56B | 3.66B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.98 | 48.14B | 6.30B | 1.07B | 1.34B | 1.8406 |
Neogen Corp Stock (NEOG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-29 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2023-06-16 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2017-12-05 | Fortgesetzt | ROTH Capital | Neutral |
| 2017-07-14 | Eingeleitet | CL King | Neutral |
| 2014-06-05 | Eingeleitet | William Blair | Mkt Perform |
| 2011-03-31 | Hochstufung | Hilliard Lyons | Underperform → Neutral |
| 2009-09-25 | Bestätigt | Roth Capital | Buy |
| 2009-07-22 | Bestätigt | Roth Capital | Buy |
| 2009-03-20 | Bestätigt | Roth Capital | Buy |
| 2009-01-07 | Bestätigt | Roth Capital | Buy |
| 2008-09-25 | Bestätigt | Roth Capital | Buy |
| 2008-01-04 | Bestätigt | Roth Capital | Buy |
| 2007-09-28 | Bestätigt | Roth Capital | Buy |
| 2007-07-25 | Bestätigt | Roth Capital | Buy |
| 2007-07-09 | Bestätigt | Roth Capital | Buy |
| 2007-05-08 | Eingeleitet | Susquehanna Financial | Positive |
Alle ansehen
Neogen Corp Aktie (NEOG) Neueste Nachrichten
Vanguard Capital Management holds 11.16M shares in Neogen (NEOG) - Stock Titan
Vanguard Portfolio Management reports 12.9M Neogen shares (NEOG) on 13G - Stock Titan
Neogen (NASDAQ:NEOG) Stock Crosses Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
3 Reasons NEOG is Risky and 1 Stock to Buy Instead - Yahoo! Finance Canada
Is AOAC-Certified Rapid Listeria Test Altering The Investment Case For Neogen (NEOG)? - Sahm
NEOG Price Today: Neogen Corp. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Neogen (NEOG) Achieves Certification for Rapid Listeria Testing Method - GuruFocus
Neogen’s Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification - Yahoo Finance
Crude Oil Surges 3%; Neogen Shares Fall After Q3 Results - Sahm
Round Rock Advisors LLC Purchases 131,684 Shares of Neogen Corporation $NEOG - MarketBeat
Neogen Corp stock (US6404911066): Is its animal health focus strong enough to unlock new upside? - AD HOC NEWS
Neogen Corporation 8-K SEC Filing April 20, 2026 – Key Entity Information, Trading Symbol, and Nasdaq Listing - Minichart
Neogen schedules investor tours at Lansing facility, updates on Petrifilm validation By Investing.com - Investing.com
Neogen to host investor tours as Petrifilm SKUs complete operational qualifications - TradingView
Neogen (NEOG) plans investor tours to showcase Petrifilm validation progress - Stock Titan
Neogen Corporation (NASDAQ:NEOG) Given Average Rating of "Hold" by Analysts - MarketBeat
Neogen (NEOG) Is Down 7.9% After Raising 2026 Revenue Guidance Amid Wider Net Loss And New CLO – Has The Bull Case Changed? - simplywall.st
5 Must-Read Analyst Questions From Neogen’s Q1 Earnings Call - Yahoo Finance
Neogen Corp. Opens with 5.61% Gain, Outperforming S&P 500's 2.51% Rise - Markets Mojo
CapEx per share of Neogen Corp – FWB:NG2 - TradingView — Track All Markets
NEOGEN (NEOG) Chief Legal Officer Stacey Evans files insider ownership report - Stock Titan
Neogen Reshapes Portfolio Around Food Safety With Divestitures And Job Cuts - Sahm
Neogen tops estimates as food safety segment drives growth - MSN
The Bull Case For Neogen (NEOG) Could Change Following Q3 Loss, Guidance Hike, Genomics Sale News - Yahoo Finance
Assessing Neogen (NEOG) Valuation After Earnings Beat And Higher Full Year Guidance - Yahoo Finance
Neogen (NASDAQ:NEOG) Downgraded by Wall Street Zen to Hold - MarketBeat
Neogen (NASDAQ:NEOG) Shares Down 6.9%Here's Why - MarketBeat
Neogen Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
BlackBerry, Constellation Brands And 3 Stocks To Watch Heading Into Thursday - Sahm
Neogen Corporation (NASDAQ:NEOG) Q3 2026 Earnings Call Transcript - Insider Monkey
Inside Neogen Corp (NEOG): A Comprehensive SWOT Breakdown - GuruFocus
Neogen Corporation Q3 2026 10-Q Report: Financial Statements, Risk Factors & Management Discussion - Minichart
Neogen beats estimates on strong food safety growth By Investing.com - Investing.com Canada
Crude oil surges 3%; Neogen shares fall after Q3 results - MSN
William Blair reiterates Neogen stock rating citing execution improvements - Investing.com
Neogen Corp (NEOG) Q3 2026 Earnings Call Highlights: Navigating Growth and Challenges - GuruFocus
[10-Q] NEOGEN CORP Quarterly Earnings Report - Stock Titan
Neogen (NASDAQ:NEOG) Shares Gap DownShould You Sell? - MarketBeat
Neogen (NASDAQ:NEOG) Mixed Quarter Reshapes Market View In Nasdaq Composite - Kalkine Media
Neogen earnings beat by $0.03, revenue topped estimates By Investing.com - Investing.com South Africa
Neogen Q3 FY26 slides: Food Safety growth offsets Animal Safety decline - Investing.com
Neogen Corp reports results for the quarter ended February 28Earnings Summary - TradingView
Neogen (NEOG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Neogen Q3 Earnings Call Highlights - MarketBeat
Neogen (NASDAQ:NEOG) Issues Quarterly Earnings Results - MarketBeat
Neogen (NEOG) Q3 2025 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Neogen beats Q3 2026 forecasts but stock dips - Investing.com
Neogen (NEOG) Q3 FY2026 Earnings: GAAP EPS -$0.08 misses -$0.05 - GuruFocus
Neogen Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 - marketscreener.com
Neogen stock tumbles. Why a guidance hike and earnings beat aren’t helping - MSN
NEOGEN CORP (NASDAQ:NEOG) Posts Q3 Beat but Cuts Outlook as Animal Safety Segment Slumps - ChartMill
Finanzdaten der Neogen Corp-Aktie (NEOG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Neogen Corp-Aktie (NEOG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nassif Mikheal | CEO |
Jan 26 '26 |
Buy |
9.86 |
25 |
246 |
657 |
| Nassif Mikheal | CEO |
Feb 02 '26 |
Buy |
10.00 |
24 |
240 |
681 |
| Nassif Mikheal | CEO |
Jan 16 '26 |
Buy |
9.33 |
137 |
1,279 |
632 |
| Naemura David H. | Former CFO |
Dec 01 '25 |
Option Exercise |
5.98 |
12,912 |
77,214 |
93,936 |
| Nassif Mikheal | CEO |
Nov 03 '25 |
Buy |
6.25 |
177 |
1,106 |
495 |
| BOREL JAMES C | Director |
Oct 27 '25 |
Option Exercise |
6.19 |
1,777 |
11,000 |
96,347 |
| CAPELLO JEFFREY D | Director |
Oct 27 '25 |
Option Exercise |
6.19 |
1,777 |
11,000 |
32,502 |
| Green Ronald D | Director |
Oct 27 '25 |
Option Exercise |
6.19 |
1,777 |
11,000 |
18,654 |
| Gupta Aashima | Director |
Oct 27 '25 |
Option Exercise |
6.19 |
1,777 |
11,000 |
27,790 |
| RODRIGUEZ RAFAEL A | Director |
Oct 27 '25 |
Option Exercise |
6.19 |
1,777 |
11,000 |
20,821 |
0.57%
1.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):